| Subject: | FDA Issues Notice about Heparin Sodium Injection 10,000 units/mL and HEP-LOCK U/P 10 units/mL Medication Errors |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 9 Feb 2007 - 12:00 am |
| Audience: Pharmacists, neonatology/pediatric healthcare professionals
The FDA and Baxter have notified healthcare professionals of the potential for life threatening medication errors involving two Heparin products:
Heparin Sodium Injection 10,000 units/mL
HEP-LOCK U/P 10 units/mL.
Baxter is aware of fatal medication errors that have occurred when two Heparin products with shades of... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
